Holen Sie sich die Stockscreener-App
172.07
6.10%
9.90
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EFX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$162.17
Offen:
$164.24
24-Stunden-Volumen:
2.19M
Relative Volume:
1.24
Marktkapitalisierung:
$20.49B
Einnahmen:
$6.28B
Nettoeinkommen (Verlust:
$703.80M
KGV:
30.30
EPS:
5.6784
Netto-Cashflow:
$1.14B
1W Leistung:
+13.26%
1M Leistung:
-2.29%
6M Leistung:
-19.60%
1J Leistung:
-34.42%
1-Tages-Spanne:
$163.69
$172.23
1-Wochen-Bereich:
$151.84
$172.23
52-Wochen-Spanne:
$150.75
$275.91
Equifax Inc Stock (EFX) Company Profile
Firmenname
Equifax Inc
Sektor
Branche
Telefon
(404) 885-8000
Adresse
1550 PEACHTREE ST NW, ATLANTA, GA
Compare EFX vs VRSK, BAH, FCN, HURN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
172.07 | 18.90B | 6.28B | 703.80M | 1.14B | 5.6784 |
VRSK
Verisk Analytics Inc
|
188.35 | 23.52B | 3.10B | 910.20M | 1.13B | 6.5659 |
BAH
Booz Allen Hamilton Holding Corp
|
62.45 | 7.28B | 11.22B | 845.00M | 951.00M | 6.8984 |
FCN
Fti Consulting Inc
|
153.59 | 4.49B | 3.87B | 266.68M | 255.97M | 8.4148 |
HURN
Huron Consulting Group Inc
|
97.16 | 1.46B | 1.75B | 103.75M | 103.64M | 5.8551 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Fortgesetzt | BofA Securities | Buy |
| 2025-10-13 | Eingeleitet | Oppenheimer | Outperform |
| 2025-10-01 | Eingeleitet | Seaport Research Partners | Neutral |
| 2025-07-10 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-06-23 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-10 | Fortgesetzt | BofA Securities | Buy |
| 2025-04-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-20 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-14 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2025-02-11 | Herabstufung | Argus | Buy → Hold |
| 2024-12-16 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-01 | Eingeleitet | UBS | Buy |
| 2024-09-19 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-08-13 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-09 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-01-11 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2024-01-08 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-01-04 | Bestätigt | Needham | Buy |
| 2023-12-19 | Eingeleitet | Oppenheimer | Outperform |
| 2023-12-18 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-08 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-11-20 | Eingeleitet | Citigroup | Buy |
| 2023-07-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-11-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2022-10-21 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-10-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-21 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-30 | Eingeleitet | Deutsche Bank | Hold |
| 2022-03-11 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-31 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-01-27 | Hochstufung | Truist | Hold → Buy |
| 2022-01-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-01-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-22 | Hochstufung | Argus | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Neutral |
| 2021-07-08 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-12-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-12-11 | Hochstufung | Stifel | Hold → Buy |
| 2020-12-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-10-07 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-10-06 | Eingeleitet | Needham | Buy |
| 2020-07-10 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-06-09 | Herabstufung | SunTrust | Buy → Hold |
| 2020-05-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-04-06 | Herabstufung | Argus | Buy → Hold |
| 2020-03-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-02 | Hochstufung | Exane BNP Paribas | Underperform → Outperform |
| 2020-01-17 | Hochstufung | Argus | Hold → Buy |
| 2019-11-22 | Eingeleitet | Jefferies | Buy |
| 2019-03-15 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2019-02-05 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2018-12-07 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-10-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-04-10 | Eingeleitet | BofA/Merrill | Underperform |
| 2017-12-14 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Equifax Inc Aktie (EFX) Neueste Nachrichten
Equifax stock keeps the focus on its data and verification platform. - AD HOC NEWS
Equifax : May 2026 U.S. National Consumer Credit Trends Report - marketscreener.com
Price to sales forward of Equifax, Inc. – NYSE:EFX - TradingView
Price to book forward of Equifax Inc. – LSX:854618 - TradingView
3 Reasons EFX is Risky and 1 Stock to Buy Instead - Yahoo! Finance Canada
Enterprise value to EBITDA forward of Equifax Inc. Shs Cert Deposito Arg Repr 0.0625 Sh – BCBA:EFXD - TradingView
Reasons Why Investors Should Hold Equifax Stock in Their Portfolio - Yahoo Finance Singapore
Equifax (EFX) Expands Patent Portfolio with 39 New Innovations - GuruFocus
Equifax secures 39 patents in first half of 2026 - Investing.com
Equifax secures 39 patents in first half of 2026 By Investing.com - Investing.com Canada
Equifax Expands Strategic Patent Portfolio in First Half of 2026 - Equifax
Equifax opens the week with analyst focus, shares steady on NYSE - AD HOC NEWS
NOTO partners with Equifax UK to support the delivery of real-time AML compliance - Yahoo Finance
Equifax’s Index Exit and Tighter Meeting Rules Could Be A Game Changer For Equifax (EFX) - simplywall.st
Equifax Secures 39 New Global Patents to Drive AI Innovation - Intellectia AI
Actually you're not getting that $125 from Equifax, warns the FTC - Mashable
Equifax Inc.(NYSE: EFX) dropped from Russell Midcap Growth Benchmark - marketscreener.com
Equifax consensus and calendar, shares steady on NYSE - AD HOC NEWS
Equifax outlines data and analytics strategy, shares anchored in the S&P 500 - AD HOC NEWS
Equifax Inc.(NYSE: EFX) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Equifax Inc.(NYSE: EFX) dropped from Russell 1000 Growth Benchmark - marketscreener.com
Equifax Complete Premier from Equifax Inc.layered credit monitoring for families - AD HOC NEWS
Equifax guidance and credit trends, shares on NYSE in sector focus - Ad-hoc-news.de
Equifax BusinessConnect from Equifax Inc.credit insights tuned for mid-sized lenders - Ad-hoc-news.de
A Look at Equifax Inc (EFX) After 4.3% Gain -- GF Value $287.38 vs Price $158.48 - GuruFocus
Equifax Inc. stock outperforms competitors on strong trading day - MarketWatch
The Equifax Ignite Analytics from Equifax Inc.cloud credit data under tighter control - Ad-hoc-news.de
Equifax price target cut by Goldman Sachs, shares trade in a lower range - Ad-hoc-news.de
Goldman Sachs Adjusts Price Target on Equifax to $173 From $200, Maintains Neutral Rating - Moomoo
Equifax Inc (EFX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Equifax Inc Shs Unsponsored Brazilian Depositary Receipt Repr 1 Sh Actuals & Estimates (BMFBOVESPA:EFXB31) - TradingView
Critics of credit report costs blast Equifax after bureau defends tri-merge reporting - Scotsman Guide
Equifax Inc (EFX) Stock Down 3.6% -- Now Undervalued? GF Score: 77/100 - GuruFocus
Equifax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
EFX Forecast — Price Target — Prediction for 2027 - TradingView
Equifax Inc. Actuals & Estimates (NYSE:EFX) - TradingView
Equifax Inc. Actuals & Estimates (VIE:EFX) - TradingView
Equifax opens the week with a clear analyst picture, shares trade steadily on NYSE - Ad-hoc-news.de
Credit Bureaus Remain Powerful, But TransUnion Offers The Better Setup Over Equifax - Seeking Alpha
Reklaim Credit Solutions Co-Founders Sam Fensterstock and Bob McCarthy Step Into Chief Revenue Officer and Chief Technology Officer Roles Ahead of Q3 2026 Launch - GlobeNewswire Inc.
Equifax cautious on technicals, shares trade below key resistance - Ad-hoc-news.de
EFX News | EQUIFAX INC (NYSE:EFX) - ChartMill
Home owned by former Equifax CEO sells for $13 million - Jacksonville Daily Record
Understanding the Setup: (EFX) and Scalable Risk - Stock Traders Daily
Equifax opens the week with clear analyst backing, shares trade in a wide range - AD HOC NEWS
Equifax | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers - Moomoo
Equifax stock hits 52-week low at $151.91 - Investing.com
Equifax stock hits 52-week low at $151.91 By Investing.com - Investing.com Australia
Equifax opens the week with mixed signals, shares between support and resistance - AD HOC NEWS
Equifax Ignite from Equifax Inc.analytics platform pushes credit data deeper into the cloud - AD HOC NEWS
Integrated Quantum Appoints Former Equifax VP of Engineering Gustin Prudner to Accelerate Commercialization of VEIL(TM) and Expand Its AI Infrastructure Portfolio - TMX Newsfile
Finanzdaten der Equifax Inc-Aktie (EFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):